0.7822
0.78 (-1.47%)
As of Jun 14, 2022
Graybug Vision, Inc. [GRAY]
Source:
Company Overview
Graybug Vision, Inc is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of ocular diseases. Our novel proprietary technologies are designed to release drugs in ocular tissue at a controlled rate for up to 12 months in order to improve patient compliance, reduce healthcare burdens and, ultimately, deliver better clinical outcomes.
Country | United States |
Headquarters | la jolla, california |
Phone Number | 858-952-5500 |
Industry | manufacturing |
CEO | Frederic Guerard, Pharm.D. |
Website | www.graybug.vision |